Table 2.
Characterisation of the study population according to cardiometabolic risk factors (Mann-Whitney U-test; median (IQR))
| Females (n = 91) | Males (n = 89) | |
|---|---|---|
| RRsys, mm Hg | 118.0 (110.0–124.0) | 120.0 (110.0–129.0) |
| RRdias, mm Hg | 70.0 (66.0–76.0) | 71.0 (66.0–75.0) |
| Triglycerides, mg/dl | 70.0 (53.8–95.5) | 69.0 (49.0–86.0) |
| Cholesterol, mg/dl | 151.0 (134.8–174.3) | 143.0 (127.0–164.0) |
| LDL-C, mg/dl | 76.7 (61.0–91.5) | 69.1 (57.8–88.0) |
| HDL-C, mg/dl | 60.5 (52.0–70.0) | 56.0 (47.0–67.0) |
| Glucose, mg/dl | 89.0 (85.0–93.0) | 90.0 (87.0–95.0) |
| HOMA-IR, mmol/l × µU/ml | 2.4 (1.7–3.1) | 2.1 (1.6–2.7) |
HDL-C = High-density lipoprotein cholesterol; HOMA-IR = homeostasis model assessment of insulin resistance; LDL-C = low-density lipoprotein cholesterol; RRdias = diastolic blood pressure; RRsys = systolic blood pressure.